Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celltrion concludes enrolment for Phase II clinical trial of COVID-19 monoclonal treatment

expresspharmaNovember 26, 2020

Tag: COVID-19 , CT-P59 , Clinical Trial

PharmaSources Customer Service